A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization
about
Histidine-rich glycoprotein binds to cell-surface heparan sulfate via its N-terminal domain following Zn2+ chelationPlasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesisThe anti-angiogenic His/Pro-rich fragment of histidine-rich glycoprotein binds to endothelial cell heparan sulfate in a Zn2+-dependent mannerRegulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavageC-terminal ADAMTS-18 fragment induces oxidative platelet fragmentation, dissolves platelet aggregates, and protects against carotid artery occlusion and cerebral strokeHistidine-rich glycoprotein protects from systemic Candida infectionHistidine-rich glycoprotein uptake and turnover is mediated by mononuclear phagocytesCrystal structure of histidine-rich glycoprotein N2 domain reveals redox activity at an interdomain disulfide bridge: implications for angiogenic regulationEnhanced platelet activation mediates the accelerated angiogenic switch in mice lacking histidine-rich glycoproteinFunctional Regulation of the Plasma Protein Histidine-Rich Glycoprotein by Zn2+ in Settings of Tissue InjuryHistidine-rich glycoprotein can prevent development of mouse experimental glioblastoma.Histidine-rich glycoprotein modulates the anti-angiogenic effects of vasculostatinThe histidine-rich glycoprotein A1042G polymorphism and recurrent miscarriage: a pilot study.New method for purifying histidine-rich glycoprotein from human plasma redefines its functional properties.Altered protein expression in serum from endometrial hyperplasia and carcinoma patients.Role of cystatins in tumor neovascularization.Increased peri-ductal collagen micro-organization may contribute to raised mammographic density.Histidine-rich glycoprotein function in hepatocellular carcinoma depends on its N-glycosylation status, and it regulates cell proliferation by inhibiting Erk1/2 phosphorylationTumor-associated macrophages as incessant builders and destroyers of the cancer stroma.18O proteomics reveal increased human apolipoprotein CIII in Hispanic HIV-1+ women with HAART that use cocaineAntimicrobial peptides: key components of the innate immune system.Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment.Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.Histidine-rich glycoprotein specifically binds to necrotic cells via its amino-terminal domain and facilitates necrotic cell phagocytosis.Divalent metal binding by histidine-rich glycoprotein differentially regulates higher order oligomerisation and proteolytic processing.The presence of histidine-rich glycoprotein in the female reproductive tract and in embryos.Histidine-rich glycoprotein exerts antibacterial activity.Native electrospray mass spectrometry approaches to probe the interaction between zinc and an anti-angiogenic peptide from histidine-rich glycoprotein.
P2860
Q24292816-FD8D72B2-25F5-40FF-9AF9-EBA92F8C99AAQ24293734-CD2A5E82-10C9-4246-9F9D-4DFFE264705DQ24302060-50EF4430-2532-406D-9B3D-E41E42869D31Q24310228-ECD4CD27-3BE0-41AD-A692-B24FB2244EE3Q24310892-5017A89D-6247-42DE-ADFF-02F12541FC56Q24313429-B203C0FB-3F30-40D6-975D-A48317B2F2B0Q27347296-2D311E7F-EC90-4755-98B9-4C3DBD158961Q27681610-FF610603-E7EF-4E14-B184-AD59D4171B31Q28586472-6CD2D596-0A72-4DC9-A440-AD55220F4C1EQ30399403-CE7FA5A4-8B06-4824-8F18-58A6DA46CD33Q33521707-D2BA34ED-F391-4DF0-A5D4-DFDFE8D027F4Q33745306-B9BB00FF-AE16-4A0C-AD7C-B522AF6CC511Q33986046-28EE571B-CF14-4447-AB7C-4FA87A6E5B72Q34663359-4A504899-297C-47EF-A125-B6449F511003Q34989853-EF864284-8DDD-478F-9F7A-F8145F1081D8Q36429583-45C42AEE-7BA5-4CF2-9969-64D13FDDB10BQ36446246-069AA73B-BA49-4C84-B8CD-02306CE5C4B4Q36557542-2DD66FF8-FC26-4D7F-8DFA-3D2D583792CFQ37148134-0EE8F36C-6DAF-48A5-92FE-C2DC2FA6BB2FQ37161083-822E5BA6-A121-4C09-BD7A-6F1DD86DE51CQ37954721-F065BD9C-F498-43A8-ADBD-430C2F137883Q37974937-E38E395E-AEF3-4464-8C5E-475255F891FCQ38418286-92E130D5-7414-4926-A2F1-C93EA58D9BD3Q40384047-ACF504C6-C977-47E4-9410-645FEC0A860BQ51279277-10F38A5A-BD63-41C3-B67E-1B8203D9B161Q51552225-E00FFE84-5B39-43BA-A4FE-5D7AC418A67DQ54448358-82B8F79F-4280-40A5-88F2-14AE196EA130Q55237509-55CA08E9-DA24-4CB0-A2FC-E38F39BF9549
P2860
A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization
@ast
A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization
@en
A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization
@en-gb
A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization
@nl
type
label
A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization
@ast
A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization
@en
A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization
@en-gb
A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization
@nl
prefLabel
A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization
@ast
A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization
@en
A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization
@en-gb
A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization
@nl
P2093
P1433
P1476
A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization
@en
P2093
Anna-Karin Olsson
Chunsik Lee
Cornelia Oellig
Helena Larsson
Ingemar Björk
Irja Johansson
Johan Dixelius
Lena Claesson-Welsh
P304
P356
10.1158/0008-5472.CAN-03-1941
P407
P577
2004-01-15T00:00:00Z